SI
SHOULDER INNOVATIONS, INC.
NYSE · Healthcare · Medical - Specialties · US
$20.32
−0.34%Margins
Gross margin
77.3%
EBITDA margin
-55.0%
EBIT margin
-58.5%
Net margin
-58.3%
FCF margin
-78.4%
-28.2%
Return on equity
-23.0%
Return on assets
-25.3%
Return on invested capital
0.38x
Asset turnover
-$37.1M
Cash from operations
$4.75
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026